Dr. Hönle AG Statistics

Total Valuation

Dr. Hönle AG has a market cap or net worth of EUR 51.89 million. The enterprise value is 98.93 million.

Market Cap	51.89M
Enterprise Value	98.93M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Dr. Hönle AG has 6.06 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	6.06M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	12.89%
Float	4.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	34.59
PS Ratio	0.54
PB Ratio	0.66
P/TBV Ratio	0.78
P/FCF Ratio	36.65
P/OCF Ratio	14.45
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.14, with an EV/FCF ratio of 69.87.

EV / Earnings	-7.63
EV / Sales	1.03
EV / EBITDA	17.14
EV / EBIT	265.95
EV / FCF	69.87

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.68.

Current Ratio	1.89
Quick Ratio	0.73
Debt / Equity	0.68
Debt / EBITDA	9.48
Debt / FCF	38.30
Interest Coverage	0.15

Financial Efficiency

Return on equity (ROE) is -14.73% and return on invested capital (ROIC) is 0.14%.

Return on Equity (ROE)	-14.73%
Return on Assets (ROA)	0.12%
Return on Invested Capital (ROIC)	0.14%
Return on Capital Employed (ROCE)	0.26%
Revenue Per Employee	164,759
Profits Per Employee	-22,176
Employee Count	590
Asset Turnover	0.60
Inventory Turnover	1.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.98% in the last 52 weeks. The beta is 1.58, so Dr. Hönle AG's price volatility has been higher than the market average.

Beta (5Y)	1.58
52-Week Price Change	-56.98%
50-Day Moving Average	9.15
200-Day Moving Average	10.80
Relative Strength Index (RSI)	49.14
Average Volume (20 Days)	2,488

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Hönle AG had revenue of EUR 96.38 million and -12.97 million in losses. Loss per share was -2.14.

Revenue	96.38M
Gross Profit	59.72M
Operating Income	321,000
Pretax Income	-11.74M
Net Income	-12.97M
EBITDA	4.35M
EBIT	321,000
Loss Per Share	-2.14

Full Income Statement

Balance Sheet

The company has 7.47 million in cash and 54.23 million in debt, giving a net cash position of -46.77 million or -7.71 per share.

Cash & Cash Equivalents	7.47M
Total Debt	54.23M
Net Cash	-46.77M
Net Cash Per Share	-7.71
Equity (Book Value)	79.19M
Book Value Per Share	13.02
Working Capital	27.46M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.59 million and capital expenditures -2.17 million, giving a free cash flow of 1.42 million.

Operating Cash Flow	3.59M
Capital Expenditures	-2.17M
Free Cash Flow	1.42M
FCF Per Share	0.23

Full Cash Flow Statement

Margins

Gross margin is 61.96%, with operating and profit margins of 0.33% and -13.46%.

Gross Margin	61.96%
Operating Margin	0.33%
Pretax Margin	-12.18%
Profit Margin	-13.46%
EBITDA Margin	4.52%
EBIT Margin	0.33%
FCF Margin	1.47%

Dividends & Yields

Dr. Hönle AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-25.00%
FCF Yield	2.73%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Dr. Hönle AG has an Altman Z-Score of 1.89. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.89
Piotroski F-Score	n/a